Wed, Oct. 2
2013
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
Tue, Aug. 6
2013
MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
Thu, May 16
2013
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
Thu, Oct 25
2012
MultiCell Technologies Files SEC form 8-K, Entry into a Material Definitive Agreement
Wed, Oct 24
2012
MultiCell Technologies Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
Mon, Oct 22
2012
Grant G. Miller Joins Board of MultiCell Technologies
Fri, Oct 19
2012
MultiCell Technologies Financials
Mon, Oct 15
2012
MultiCell Technologies Files SEC form 10-Q, Quarterly Report
Thu, Sept 27
2012
MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting
Thu, Sept 6
2012
Scott Lukeman Ph.D., Joins Board of MultiCell Technologies
Thu, Sept 6
2012
MultiCell Technologies Files SEC form 8-K, Change in Directors or Principal Officers
Tue, Aug 14
2012
MultiCell Announces Results of Shareholders’ Meeting
Mon, Aug 13
2012
MultiCell Technologies Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial State
Fri, Aug 10
2012
MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
Mon, July 16
2012
MultiCell Technologies Files SEC form 10-Q, Quarterly Report
Mon, Apr 16
2012
MultiCell Technologies Files SEC form 10-Q, Quarterly Report
Sat, Mar
3 2012
MultiCell Technologies Financials
Mon, Jul 11
2011
  MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
Tue, May 31
2011 8:30 AM
  MultiCell Technologies is Granted Stem Cell Patent
Wed, Feb 23
2011 10:22 AM
  Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
Tue, Oct 19
2010
  MultiCell’s Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
Thu, Apr 26
2010 8:00 AM
  MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
Thu, Aug 20
2009 8:00 AM
  MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines
Thu, Mar 19
2009 9:40 AM
  MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
Wed, Dec 26
2007 5:14 PM
  MultiCell Technologies To Increase Focus on Therapeutic Candidates
Wed, Oct 10
2007 10:23 AM
  MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
Thu, July 19
2007 8:00 AM
  MultiCell Technologies and Fusion Capital Terminate Common Stock Purchase Agreement
Thu, May 03
2007 9:00 AM
  MultiCell Technologies Receives Two International Trademark Protections
Tue, Apr 24
2007 8:00 AM
  MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 Cell Line for Drug Discovery/ADMETOX Applications
Wed, Apr 18
2007 9:00 AM
  MultiCell Technologies Signs Key Formulation and Supply Agreement With Merck KGaA & Co. Spittal/Drau
Mon, Apr 9
2007 9:30 AM
  MultiCell Technologies Signs Key Supply Agreement With Lundbeck Pharmaceuticals Italy S.p.A.
Wed, Mar 21
2007 10:38 AM
  MultiCell Technologies Announces a New Class of Patented Therapeutics
Tue, Mar 6
2007 7:28 PM
  MultiCell Technologies Completes Private Financing Agreement with La Jolla Cove Investors for up to $13 Million to Support Development of Advanced Therapeutics
Thu, Feb 15
2007 3:30 AM
  MultiCell Technologies Announces Prospective Cancer Treatment Drug
Tue, Feb 6
2007 3:30 AM
  MultiCell Technologies Announces Progress for MCT-125’s Anticipated Phase IIb Clinical Trial
Thu, Jan 11
2007 6:30 AM
  MultiCell Technologies’ Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer